Connie Wierman, who has more than 25 years of biopharmaceutical experience, has been named Vice President of Biopharmaceutical Development at Theorem Clinical Research, a US-based provider of clinical research and development services. She will lead the company’s oncology therapeutic focus for the biopharmaceutical business unit.
‘We’re building a team of top industry professionals at all levels of the Theorem organisation and Connie fits right into that vision,’ said Theorem President and CEO John Potthoff. ‘She has built an impressive career with an emphasis on the global clinical development of oncology therapies. We count on her to provide an excellent operational environment and successful outcomes for our clients.’
Wierman held a number of executive posts at leading industry firms prior to joining Theorem, including Vice President of Clinical Development in oncology at INC Research. She was also responsible for developing and leading a team for ILEX (now Sanofi-Aventis) to support the research and educational goals for oncology agents under development and those recently launched.
